RNS Number : 0700O
TruFin PLC
13 May 2024
 

13 May 2024

TruFin plc 

("TruFin" or the "Company" or together with its subsidiaries "TruFin Group" or the "Group")


Trading Update


TruFin is pleased to announce that its trading performance for the 12 months ended 31 December 2024 is expected to be significantly ahead of market expectations. The Group is now expected to be EBITDA positive for the full year.

This outperformance has been driven by Playstack Ltd's launch of Balatro, their fastest selling PC / console game, and the newly launched Abiotic Factor, which surpassed 250,000 units sold in the first 8 days of sales.

The rest of the Group has also seen robust performance during the year to date.

 

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.


Enquiries:

TruFin plc
James van den Bergh, Chief Executive Officer
Kam Bansil, Investor Relations


0203 743 1340
07779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)
Chris Clarke
Edward Thomas

0203 100 2000


About TruFin plc:

TruFin plc is the holding company of an operating group comprising four growth-focused technology businesses operating in niche markets: early payment provision, invoice finance and console games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGMKLZGGDZM